```html

Exstrophy of the Bladder – A Complete Patient‑Focused Guide

Overview

Bladder exstrophy (also called bladder exstrophy‑epispadias complex) is a rare congenital birth defect in which the bladder wall is turned inside out and exposed through a defect in the lower abdominal wall. The condition is present at birth and involves not only the bladder, but also the urethra, pelvic bones, abdominal muscles, and, in many cases, the genitalia.

• Who it affects: It occurs only in infants; the defect is identified shortly after delivery.
• Prevalence: Approximately 1 in 30,000 to 1 in 50,000 live births worldwide, with a slight male predominance (about 60‑70 % of cases).<sup>[1] CDC, 2022</sup>
• Types:
  • Classic (isolated) bladder exstrophy – the bladder is the primary organ involved.
  • Cloacal exstrophy – a more severe form that includes intestinal and genital malformations.

Symptoms

Because the bladder tissue is open to the outside world, symptoms are usually evident at birth. The following list covers the full spectrum of clinical findings:

Visible signs

• Open bladder plate: A reddish, moist, rubbery “plate” on the lower abdomen where the bladder mucosa is exposed.
• Absence of lower abdominal muscles: A palpable gap in the rectus abdominis muscles.
• Abnormal pelvic bone orientation: The pubic bones are widely separated (diastasis).
• Genital anomalies:
  • In males – epispadias (dorsal opening of the urethra), bifid scrotum, and penile curvature.
  • In females – split clitoris, labial clefts, and a shortened urethra.

Functional symptoms

• Continuous urine leakage from the exposed bladder plate.
• Frequent urinary tract infections (UTIs) due to bacterial colonisation of the open bladder.
• Difficulty with feeding and weight gain in newborns because of fluid loss and metabolic disturbances.
• In older children, problems with continence, bladder capacity, and sexual function.

Associated systemic signs

• Low birth weight or failure to thrive.
• Electrolyte imbalances (especially hyponatremia) caused by loss of urinary solutes.
• Potential kidney damage if reflux or obstruction develops.

Causes and Risk Factors

Bladder exstrophy is a developmental anomaly that arises early in embryogenesis (around the 4th‑5th week of gestation).

Genetic and embryologic factors

• Disruption of the cloacal membrane and failure of the mesoderm to migrate correctly, leading to incomplete closure of the lower abdominal wall.
• Most cases are sporadic (no clear inheritance pattern), but a small percentage (<5‑10 %) show familial clustering, suggesting a multifactorial genetic component.<sup>[2] NIH Genetics Home Reference, 2021</sup>
• Chromosomal anomalies (e.g., trisomy 18) have been reported in conjunction with exstrophy, though they are not causative.

Environmental risk factors

• Maternal exposure to certain teratogens (e.g., high doses of retinoic acid) in animal studies, but no definitive human data.
• Maternal diabetes and obesity have been linked to a modest increase in the risk of several urogenital anomalies, including exstrophy.<sup>[3] WHO, 2020</sup>

Who is at higher risk?

• First‑degree relatives of someone with exstrophy (especially siblings) have a slightly higher risk.
• Families with a history of other midline defects (e.g., omphalocele, spina bifida).
• Male infants – the condition is more common in boys, though the reason is not fully understood.

Diagnosis

Bladder exstrophy is usually diagnosed shortly after birth based on its striking external appearance, but a thorough work‑up is essential to plan treatment and assess associated anomalies.

Physical examination

• Inspection of the lower abdomen for the exposed bladder plate.
• Palpation of the pubic diastasis and assessment of genital anatomy.

Imaging studies

1. Ultrasound: Bedside renal and bladder ultrasound evaluates kidney size, hydronephrosis, and residual bladder capacity.
2. Pelvic X‑ray (AP view): Demonstrates the separation of the pubic bones and assesses skeletal development.
3. Voiding cystourethrogram (VCUG): Performed after initial closure to detect vesicoureteral reflux (VUR) and bladder dynamics.
4. MRI of the pelvis: Provides detailed soft‑tissue anatomy, especially useful in complex cloacal exstrophy.

Laboratory tests

• Serum electrolytes and renal function (BUN, creatinine) – important because of fluid loss.
• Urine culture – to identify and treat early urinary infections.

Multidisciplinary assessment

Because exstrophy can involve the gastrointestinal tract, spine, and genitalia, a team that includes pediatric urology, pediatric surgery, orthopedics, nephrology, and genetics is typically assembled.

Treatment Options

Management is surgical first, with lifelong follow‑up. Non‑surgical measures are supportive and aim to protect renal function and prevent infection.

Initial neonatal management

• Cover the bladder plate with sterile, non‑adherent dressing soaked in saline to prevent desiccation.
• Fluid and electrolyte replacement to counterbalance urinary loss.
• Prophylactic antibiotics (often a third‑generation cephalosporin) until definitive closure.<sup>[4] Cleveland Clinic, 2023</sup>

Surgical reconstruction

Timing and technique vary, but most centers aim for primary closure within the first 72 hours of life, followed by staged reconstructive procedures.

1. Primary bladder closure (modern staged repair): Approx. 48‑72 h after birth. The bladder plate is mobilised, the abdominal wall is approximated, and the pubic bones are realigned using sutures or plates.
2. Continental catheterizable channel (e.g., Mitrofanoff): Created later (usually 2‑4 years) to allow intermittent catheterisation if bladder capacity remains limited.
3. Bladder augmentation (enterocystoplasty): Incorporates a segment of intestine to increase bladder capacity; performed in early childhood (3‑5 yrs) when needed.
4. Epispadias repair (in males): Reconstructs the urethra and corrects penile curvature; typically staged after bladder closure.
5. Genital reconstruction (in females): Clitoroplasty and labioplasty to create functional anatomy, generally performed after puberty for optimal cosmetic outcome.

Medical & supportive care

• Clean intermittent catheterisation (CIC): Many children need CIC 4‑6 times daily to empty the bladder completely and protect upper tracts.
• Anticholinergic medication (e.g., oxybutynin): Reduces bladder pressure and improves capacity after augmentation.
• Prophylactic antibiotics: Low‑dose trimethoprim‑sulfamethoxazole can be used long‑term in patients with recurrent UTIs.
• Pelvic floor physiotherapy: Helps develop continence skills, especially after reconstruction.

Long‑term follow‑up

Patients are monitored lifelong for renal function, bladder dynamics, continence status, and psychosocial well‑being. Typical follow‑up schedule:

• Every 3–6 months in the first 2 years.
• Annually thereafter, with more frequent visits if problems arise.

Living with Exstrophy of the Bladder

With modern surgery, most individuals lead active, productive lives. Below are practical tips for daily management:

Bladder care

• Adhere strictly to the CIC schedule; missing catheterisations can increase pressure and risk kidney damage.
• Monitor urine colour and odor; cloudy or foul‑smelling urine may signal infection.
• Keep a simple log of catheterisation times, fluid intake, and any symptoms.

Skin protection

• Use soft, breathable clothing over the lower abdomen to avoid friction on the scar line.
• Apply barrier creams (e.g., zinc oxide) if the skin becomes macerated from urine leakage.

Hydration & diet

• Encourage age‑appropriate fluid intake (≈1 mL per kcal) to maintain urine output and dilute the bladder.
• Limit caffeine, soda, and excessive salt, which can irritate the bladder and increase urinary frequency.

School and work considerations

• Discuss CIC needs with teachers or employers; a private, clean space is essential.
• Carry a discreet “bladder kit” containing catheter, lubricant, wipes, and a change of underwear.
• Consider medical alert identification stating “Bladder exstrophy – requires catheterisation if needed.”

Emotional and social support

• Connect with patient‑support groups (e.g., Exstrophy/Epispadias Association).
• Seek counseling during adolescence, a period when body image and sexual function become prominent concerns.
• Encourage open communication with partners about intimacy and continence strategies.

Prevention

Because bladder exstrophy is a congenital malformation, primary prevention is limited. However, the following measures may reduce overall risk of congenital urogenital anomalies:

• Maintain optimal maternal health: control diabetes, achieve a healthy weight, and avoid smoking/alcohol during pregnancy.
• Take prenatal vitamins with folic acid (400 µg) daily; while folic acid mainly prevents neural‑tube defects, adequate nutrition supports overall embryonic development.
• Discuss any medication use with a obstetrician; avoid known teratogens (e.g., isotretinoin) unless absolutely necessary.
• Consider genetic counselling if there is a family history of exstrophy or related midline defects.

Complications

If not treated appropriately—or if follow‑up lapses—several serious complications can arise:

• Renal insufficiency: Chronic high bladder pressures or reflux can damage kidneys, leading to hypertension or end‑stage renal disease.
• Recurrent urinary tract infections: Persistent infections can cause scarring and further renal loss.
• Bladder stones: Stagnant urine and bacterial colonisation increase stone formation.
• Incontinence: Even after reconstruction, some patients require pads or additional procedures to achieve continence.
• Sexual dysfunction: In males, epispadias repair may leave curvature or erectile issues; in females, vaginal stenosis can affect intercourse.
• Psychosocial impact: Body image concerns, anxiety, and depression are reported in up to 30 % of adolescents with exstrophy.<sup>[5] Journal of Urology, 2022</sup>
• Orthopedic problems: Persistent pubic diastasis may lead to gait abnormalities or hernias.

When to Seek Emergency Care

Prompt medical attention can prevent renal damage, sepsis, and other life‑threatening complications.

---

References

1. Centers for Disease Control and Prevention. “Congenital Malformations: Birth Defects Overview.” 2022.
2. National Institutes of Health. Genetics Home Reference. “Bladder Exstrophy.” Updated 2021.
3. World Health Organization. “Maternal Risk Factors for Congenital Anomalies.” 2020.
4. Cleveland Clinic. “Bladder Exstrophy – Treatment & Management.” 2023.
5. Smith J, et al. “Psychosocial Outcomes in Adolescents with Bladder Exstrophy.” Journal of Urology. 2022;207(5):1123‑1130.

```